Multivariate optimization of a method for antimony determination by hydride generation atomic fluorescence spectrometry in hair samples of patients undergoing chemotherapy against Leishmaniasis

Multivariate optimization of a method for antimony determination by hydride generation atomic fluorescence spectrometry in hair samples of patients undergoing chemotherapy against Leishmaniasis

ABSTRACT A method was developed for determination of total antimony in hair samples from patients undergoing chemotherapy against Leishmaniasis based on the administration of pentavalent antimonial drugs. The method is based on microwave assisted digestion of the samples in a pressurized system, red...

Full description

Bibliographic Details
Main Authors:	MANUELLE C. CARDOZO, DANNUZA D. CAVALCANTE, DANIEL L.F. SILVA, WALTER N.L. DOS SANTOS, MARCOS A. BEZERRA
Format:	Article
Language:	English
Published:	Academia Brasileira de Ciências 2016-01-01
Series:	Anais da Academia Brasileira de Ciências
Subjects:	Leishmaniasis antimony hair HG-AFS multivariate optimization
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652016005013105&lng=en&tlng=en

Similar Items

COMPARISON OF ORAL CHLOROQUINE WITH SYSTEMIC MEGLUMINE ANTIMONIATE IN TREATMENT OF CUTANEOUS LEISHMANIASIS
by: Muhammad Farooq, et al.
Published: (2021-02-01)

Treatment of cutaneous leishmaniasis with combination of allopurinol and low dose of meglumine antimoniate
by: A Momeni, et al.
Published: (2001-03-01)

Antimonial treatment failure rate in patients with cutaneous leishmaniasis
by: Fariba Jaffary, et al.
Published: (2018-06-01)

Predictors of an unsatisfactory response to pentavalent antimony in the treatment of American visceral leishmaniasis
by: Santos Mácia A., et al.
Published: (2002-01-01)

Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
by: Andrea Barbieri Barros, et al.
Published: (2014-07-01)

High and low doses of antimony (Sb v) in American cutaneous leishmaniasis: a five years follow-up study of 15 patients
by: MP Oliveira-Neto, et al.
Published: (1996-04-01)

Pharmacometabolomics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis
by: Deninson Alejandro Vargas, et al.
Published: (2019-06-01)

Pentavalent Antimonials: New Perspectives for Old Drugs
by: Raul R. Ribeiro, et al.
Published: (2009-06-01)

Standardization of intralesional meglumine antimoniate treatment for cutaneous leishmaniasis
by: Maria Cristina de Oliveira Duque, et al.

ELECTROCARDIOGRAPHIC CHANGES WITH STANDARD DOSE OF MEGLUMINE ANTIMONIATE THERAPY IN CUTANEOUS LEISHMANIASIS
by: Moizza Tahir, et al.
Published: (2021-08-01)

Drug resistance in leishmaniasis
by: Jaya Chakravarty, et al.
Published: (2010-01-01)

Distribution of liposome-encapsulated antimony in dogs
by: D.A. Schettini, et al.
Published: (2003-02-01)

Successful treatment of cutaneous leishmaniasis with intralesional meglumine antimoniate: A case series
by: Margarita Arboleda, et al.
Published: (2019-05-01)

Increased thiol levels in antimony-resistant Leishmania infantum isolated from treatment-refractory visceral leishmaniasis in Brazil
by: Lucas S Magalhães, et al.

Intralesional treatment with meglumine antimoniate in three patients with New World cutaneous leishmaniasis and large periarticular lesions with comorbidities
by: Maria Inês Fernandes Pimentel, et al.

Flow analysis-hydride generation-gas phase derivative molecular absorption spectrophotometric determination of antimony in antileishmanial drugs
by: Máximo Gallignani, et al.
Published: (2009-01-01)

Pharmacokinetic and parasitological evaluation of the bone marrow of dogs with visceral leishmaniasis submitted to multiple dose treatment with liposome-encapsulated meglumine antimoniate
by: D.A. Schettini, et al.
Published: (2005-12-01)

Mixed Antimony(V) Complexes with Different Sugars to Modulate the Oral Bioavailability of Pentavalent Antimonial Drugs
by: Weverson A. Ferreira, et al.
Published: (2014-04-01)

Towards a standard protocol for antimony intralesional infiltration technique for cutaneous leishmaniasis treatment
by: Rosiana Estéfane da Silva, et al.

Intralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian referral centre
by: Rosiana Estéfane da Silva, et al.
Published: (2016-08-01)

The pulsed dye laser is more effective and rapidly acting than intralesional meglumine antimoniate therapy for cutaneous leishmaniasis
by: Mohammad Radmanesh, et al.
Published: (2017-07-01)

A randomized, open-label clinical trial comparing the long-term effects of miltefosine and meglumine antimoniate for mucosal leishmaniasis
by: Raimunda Nonata Ribeiro Sampaio, et al.
Published: (2019-03-01)

An intermittent schedule is better than continuous regimen of antimonial therapy for cutaneous leishmaniasis in the municipality of Rio de Janeiro, Brazil
by: Rilza Beatriz G. de Azeredo-Coutinho, et al.
Published: (2002-10-01)

Pharmacokinetics of neutron-irradiated meglumine antimoniate in Leishmania amazonensis-infected BALB/c mice
by: Samanta Etel Treiger Borborema, et al.
Published: (2019-03-01)

Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial
by: Dario Brock Ramalho, et al.
Published: (2018-06-01)

A Pilot Randomized Clinical Trial: Oral Miltefosine and Pentavalent Antimonials Associated With Pentoxifylline for the Treatment of American Tegumentary Leishmaniasis
by: Sofia Sales Martins, et al.
Published: (2021-07-01)

Novel methods for the encapsulation of meglumine antimoniate into liposomes
by: F. Frézard, et al.
Published: (2000-07-01)

Effects of Meglumine Antimoniate Treatment on Cytokine Production in a Patient with Mucosal Leishmaniasis and Chagas Diseases Co-Infection
by: Karine Rezende-Oliveira, et al.
Published: (2020-05-01)

New onset of sinoatrial block in a young patient treated with systemic meglumine antimoniate
by: Najla Daadaa, et al.
Published: (2021-03-01)

Retrospective study of 151 patients with cutaneous leishmaniasis treated with meglumine antimoniate
by: Armando de Oliveira Schubach, et al.
Published: (2005-05-01)

Biodistribution of meglumine antimoniate in healthy and Leishmania (Leishmania) infantum chagasi-infected BALB/c mice
by: Samanta Etel Treiger Borborema, et al.
Published: (2013-08-01)

Short-Course Treatment With Imipramine Entrapped in Squalene Liposomes Results in Sterile Cure of Experimental Visceral Leishmaniasis Induced by Antimony Resistant Leishmania donovani With Increased Efficacy
by: Sandip Mukherjee, et al.
Published: (2020-11-01)

Comparisso of intralesionally injected Zink sulfate and pentavalent Antimony compound in treatment of acute cutaneous leishmaniasis
by: A.R GHafarinejhad, et al.
Published: (2000-09-01)

Nutritional status in patients with cutaneous leishmaniasis and a study of the effects of zinc supplementation together with antimony treatment
by: Miguel Guzman-Rivero, et al.
Published: (2014-11-01)

Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013)
by: Lucia Regina Brahim, et al.

Hypersensitivity eosinophilic myocarditis possibly triggered by meglumine antimoniate
by: Sergio A. Bolivar-Lozano, et al.
Published: (2024-03-01)

In Vitro Reduced Susceptibility to Pentavalent Antimonials of a <i>Leishmania infantum</i> Isolate from a Human Cutaneous Leishmaniasis Case in Central Italy
by: Aurora Diotallevi, et al.
Published: (2021-05-01)

Evaluation of clinical risk factors for systemic antimony treatment failure in patients with acute cutaneous leishmaniasis referred to dermatology clinics of Mashhad University of Medical Sciences, Iran
by: Yalda Nahidi, et al.
Published: (2023-10-01)

Effect of Antimonial Therapy on Levels of (TNF-α and IL-1β) Cytokines in Cutaneous Leishmaniasis Patients in Iraq
by: Hasan Raheem Khudhur, et al.
Published: (2019-12-01)

Leishmaniasis Recidivans in Rural Venezuela
by: Ariadna Perez Sanchez, et al.
Published: (2020-06-01)